N01.1
Rapidly progressive nephritic syndrome with focal and segmental glomerular lesions
Clinical Classification Guidelines
Inclusion Terms
- Rapidly progressive nephritic syndrome with focal and segmental hyalinosis
- Rapidly progressive nephritic syndrome with focal and segmental sclerosis
- Rapidly progressive nephritic syndrome with focal glomerulonephritis
Medical Intelligence & Overview
Rapidly Progressive Nephritic Syndrome (RPGN) with focal and segmental glomerular lesions is a serious kidney condition that leads to a swift decline in kidney function. This syndrome involves inflammation and damage to the glomeruli, which are tiny filtering units within the kidneys. If not diagnosed and managed promptly, it can progress to kidney failure. Recognizing the symptoms and understanding the causes can facilitate early intervention and management to preserve kidney health.
Causes & Symptoms
Clinical Causes: Autoimmune diseases, such as Goodpasture's syndrome or systemic vasculitis Certain infections that trigger immune responses affecting the kidneys Drugs or toxins that cause kidney inflammation Underlying chronic kidney diseases that suddenly worsen Idiopathic reasons, where no specific cause is identified
Key Symptoms: Blood in the urine (hematuria) Foamy or dark-colored urine indicating increased protein or blood Swelling in the legs, ankles, or face due to fluid retention High blood pressure Fatigue and weakness Reduced urine output in some cases Fever and malaise if inflammation is significant
Diagnostic & Treatment
Diagnosis Path: Diagnosing rapidly progressive nephritic syndrome involves a combination of clinical evaluation and laboratory tests. Blood tests assess kidney function and detect inflammation markers, such as elevated creatinine levels. Urinalysis reveals blood and protein in the urine, pointing to glomerular damage. Imaging studies like ultrasound can evaluate kidney size and structure. A kidney biopsy is often required to confirm the presence of focal and segmental glomerular lesions and to determine the specific pathology and severity of the damage.
Treatment Protocols: Treatment strategies focus on controlling inflammation, managing symptoms, and preventing further kidney damage. This may include the use of corticosteroids or immunosuppressive medications to reduce immune system activity. Blood pressure control with antihypertensive drugs is essential to decrease stress on the kidneys. In some cases, plasma exchange therapy might be necessary to remove harmful antibodies. Supportive measures like dialysis may be required if kidney function deteriorates significantly. Long-term management involves regular monitoring and addressing underlying causes whenever identified.
Clinical Advice & FAQs
Billing Guidance
Is N01.1 a billable ICD-10 code?
Yes, N01.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N01.1?
Clinical documentation must specify the nature of Rapidly progressive nephritic syndrome with focal and segmental glomerular lesions and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
